WO2026008629 - SKIN BARRIER COMPOSITION
National phase entry is expected:
Publication Number
WO/2026/008629
Publication Date
08.01.2026
International Application No.
PCT/EP2025/068686
International Filing Date
01.07.2025
Title **
[English]
SKIN BARRIER COMPOSITION
[French]
COMPOSITION POUR BARRIÈRE CUTANÉE
Applicants **
THE BOOTS COMPANY PLC
Inventors
BELL, Michael
JOHNSON, Mark
NEWTON, Victoria
Priority Data
24020228.3
05.07.2024
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2192 | |
| EPO | Filing, Examination, Granting | 10380 | |
| Japan | Filing, Examination, Granting | 2294 | |
| South Korea | Filing, Examination, Granting | 2297 | |
| USA | Filing, Examination, Granting | 5340 |
Total:
22,503
Contact Us
Abstract[English]
Use of a composition comprising (i) Vitamin B or a derivative thereof, (ii) saccharide isomerate; and (iii) a peptide, for improving skin barrier function.[French]
L'invention concerne l'utilisation d'une composition contenant (i) de la vitamine B ou un dérivé de celle-ci, (ii) un isomérate de saccharide et (iii) un peptide, pour améliorer la fonction de barrière cutanée.